Abiopharma

Williams Charles O 🟡 adjusted position in 1.6K shares (1 derivative) of Surrozen, Inc./DE (SRZN) at $19.87 Transaction Date: Jan 02, 2026 | Filing ID: 005092

NASDAQ traded attribute type Security_Name was changed. Previous value: CureVac N.V. - Ordinary Shares. New value: CureVac N.V. - Ordinary Shares.

NASDAQ traded attribute type Security_Name was changed. Previous value: Mersana Therapeutics, Inc. - Common Stock. New value: Mersana Therapeutics, Inc. - Common Stock.

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: Mersana Therapeutics, Inc. - Common Stock.

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: Mersana Therapeutics, Inc. - Common Stock.

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: CureVac N.V. - Ordinary Shares.

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: CureVac N.V. - Ordinary Shares.

Elghandour Rami 🟡 adjusted position in 208.3K shares (4 derivative) of Arcellx, Inc. (ACLX) Transaction Date: Jan 02, 2026 | Filing ID: 005086

Gilson Michelle 🟡 adjusted position in 88.5K shares (4 derivative) of Arcellx, Inc. (ACLX) Transaction Date: Jan 02, 2026 | Filing ID: 005085

WALT DAVID R 🟢 acquired 1.2K shares of Quanterix Corp (QTRX) Transaction Date: Jan 02, 2026 | Filing ID: 000001

Dambkowski Carl 🟢 acquired 83.7K shares (1 derivative) of Apogee Therapeutics, Inc. (APGE) at $75.78 ($6.3M) Transaction Date: Jan 02, 2026 | Filing ID: 001485

Director HENDERSON MICHAEL THOMAS 🟢 acquired 253.0K shares (1 derivative) of Apogee Therapeutics, Inc. (APGE) at $75.78 ($19.2M) Transaction Date: Jan 02, 2026 | Filing ID: 001484

Henderson Jane 🟡 adjusted position in 75.7K shares (1 derivative) of Apogee Therapeutics, Inc. (APGE) at $80.00 ($7.0M) Transaction Date: Jan 02, 2026 | Filing ID: 001483

Alcon - Alcon Terminates Agreement to Acquire STAAR Surgical

Hannay Michael Charles Ferguson 🟡 adjusted position in 144.8K shares (1 derivative) of BICYCLE THERAPEUTICS PLC (BCYC) at $7.08 Transaction Date: Jan 02, 2026 | Filing ID: 000002